Correct Capital Boosts Holdings in Lantheus Holdings

Summary

Correct Capital Wealth Management invested $644,000 in Lantheus Holdings, Inc. (NASDAQ: LNTH) during the first quarter, purchasing 6,595 shares. Other hedge funds also increased their holdings, with Gamma Investing LLC boosting its stake by 12,517.1%. Lantheus received multiple buy ratings from analysts, with a consensus target price of $130.50. The company reported earnings per share of $1.53, which was below expectations, and quarterly revenue of $372.76 million. Lantheus has a market capitalization of $5.78 billion and a P/E ratio of 23.73.Market Beat Additionally, Lantheus is part of the Fibre Alliance with Pfizer and Lumina Pharmaceuticals, aiming to improve fibrotic disease treatments, which could strengthen its market position.Simplywall

Impact Analysis

The event is primarily at the company level as it involves specific investment actions and financial performance related to Lantheus Holdings. Correct Capital’s investment and increased hedge fund holdings indicate confidence in the company’s potential despite the recent earnings miss. The buy ratings and the consensus target price of $130.50 suggest positive analyst sentiment. The partnership in the Fibre Alliance with major pharmaceutical companies like Pfizer could potentially enhance Lantheus’s market position by expanding its capabilities in fibrotic disease treatments.Simplywall Investors should consider the potential upside from these strategic partnerships and market positioning, balanced against the risk posed by the earnings miss and current market valuation.Market Beat